{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["33"],"submitter":["Hardy M"],"funding":["Fonds De La Recherche Scientifique - FNRS"],"pubmed_abstract":["This data article accompanies the manuscript entitled: \"Prothrombotic Disturbances of hemostasis of Patients with Severe COVID-19: a Prospective Longitudinal Observational Cohort Study\" submitted to <i>Thrombosis Research</i> by the same authors. We report temporal changes of plasma levels of an extended set of laboratory parameters during the ICU stay of the 21 COVID-19 patients included in the monocentre cohort: CRP, platelet count, prothrombin time; Clauss fibrinogen and clotting factors II, V and VIII levels, D-dimers, antithrombin activity, protein C, free protein S, total and free tissue factor pathway inhibitor, PAI-1 levels, von Willebrand factor antigen and activity, ADAMTS-13 (plasma levels); and of two integrative tests of coagulation (thrombin generation with ST Genesia) and fi"],"journal":["Data in brief"],"pagination":["106519"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7654236"],"repository":["biostudies-literature"],"pubmed_title":["Prothrombotic hemostasis disturbances in patients with severe COVID-19: Individual daily data."],"pmcid":["PMC7654236"],"pubmed_authors":["Laporte S","Hardy M","Horlait G","Testa S","Douxfils J","Bareille M","Bulpa P","Jacqmin H","Michaux I","Dogne JM","Mullier F","Lessire S","Chapelle C","Lecompte T","Dive A"],"additional_accession":[]},"is_claimable":false,"name":"Prothrombotic hemostasis disturbances in patients with severe COVID-19: Individual daily data.","description":"This data article accompanies the manuscript entitled: \"Prothrombotic Disturbances of hemostasis of Patients with Severe COVID-19: a Prospective Longitudinal Observational Cohort Study\" submitted to <i>Thrombosis Research</i> by the same authors. We report temporal changes of plasma levels of an extended set of laboratory parameters during the ICU stay of the 21 COVID-19 patients included in the monocentre cohort: CRP, platelet count, prothrombin time; Clauss fibrinogen and clotting factors II, V and VIII levels, D-dimers, antithrombin activity, protein C, free protein S, total and free tissue factor pathway inhibitor, PAI-1 levels, von Willebrand factor antigen and activity, ADAMTS-13 (plasma levels); and of two integrative tests of coagulation (thrombin generation with ST Genesia) and fi","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Dec","modification":"2025-04-04T22:52:51.017Z","creation":"2021-02-21T10:43:29Z"},"accession":"S-EPMC7654236","cross_references":{"pubmed":["33200086"],"doi":["10.1016/j.dib.2020.106519"]}}